Esperion Therapeutics OverviewEsperion Therapeutics Net Income
Profitability analysis for ESPR.
Quarterly Net Income
-$25.20M
↑ 37.72% YoY
As of Mar 2026
Annual Net Income (TTM)
$511000.00
↑ 100.33% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...